HWA
HHM Wealth Advisors’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-260
| Closed | -$31.1K | – | 820 |
|
|
2022
Q4 | $31.1K | Hold |
260
| – | – | 0.01% | 305 |
|
|
2022
Q3 | $28K | Hold |
260
| – | – | 0.01% | 307 |
|
|
2022
Q2 | $25K | Hold |
260
| – | – | 0.01% | 392 |
|
|
2022
Q1 | $24K | Hold |
260
| – | – | 0.01% | 416 |
|
|
2021
Q4 | $22K | Hold |
260
| – | – | 0.01% | 414 |
|
|
2021
Q3 | $25K | Hold |
260
| – | – | 0.01% | 385 |
|
|
2021
Q2 | $25K | Hold |
260
| – | – | 0.01% | 372 |
|
|
2021
Q1 | $25K | Hold |
260
| – | – | 0.01% | 351 |
|
|
2020
Q4 | $25K | Hold |
260
| – | – | 0.01% | 333 |
|
|
2020
Q3 | $25K | Hold |
260
| – | – | 0.01% | 297 |
|
|
2020
Q2 | $32K | Hold |
260
| – | – | 0.01% | 265 |
|
|
2020
Q1 | $23K | Buy |
+260
| New | +$23K | 0.01% | 286 |
|